![]() |
|
|
|
|
![]() |
|||
Current Studies
MetroMates Study
This study will measure how transmission risks and partnership dynamics change over time among recently HIV-infected individuals and their partners comparing their behavioral patterns with those with chronic HIV infection and no HIV infection. It will allow for partnership level analyses by actively recruiting sexual partners. Of special focus will be the role of drug use, especially methamphetamine, in affecting behaviors over time, and how partnership dynamics interact with drug use to allow for HIV transmission. metromates.bol.ucla.edu Principal Investigator: Pamina Gorbach: pgorbach@ucla.edu
Co-Investigator: Marjan Javanbakht: javan@ucla.edu Project Manager: Leonardo Colemon: leocolemon@ucla.edu CM-GALT Study:
This pilot study compares HIV replication in Gut Tissue between men who are chronic Crystal Methamphetamine (CM) users to those who are not CM users in an effort to measure the effects of Crystal Meth in this important immune system area. These data will also assist in identifying the specific biological and socio-behavioral outcomes related to chronic CM use.Principal Investigators: Peter Anton, MD, Pamina Gorbach, DrPh, Steve Shoptaw, PhD
Study Manager: Leonardo Colemon, MA Adult Film Performers Transmission Behavior & STI Prevalence. California HIV/AIDS Research Program (PI: Gorbach) 3/1/2011-2/1/2013. The study will examine the prevalence, risk behaviors, and sexual network characteristics and conduct STI testing including Chlamydia, gonorrhea, syphilis, and HIV testing among a group of 340 adult film performers in Los Angeles County through an electronic respondent driven sample.
Commercial Lubricant Use and Risk of STI UCLA AIDS Institute (PI: Gorbach) 2/1/2011-2/1/2012. With the collaboration of the PIs of Project AWARE, a large NIAID multi-site intervention trial based at 9 STD clinics throughout the US, we will obtain detailed data on lubricant use through an web-questionnaire and analyze associations of lubricant type and frequency of use with rectal gonorrhea and Chlamydial infection (rGC/CT) collected at their 6 month visit.
NICHDAdolescent Trials Networks 3/01/11- 2/28/16 Dr. Gorbach is a member of the Adolescent Medicine Leadership Group and the Community Prevention Leadership Group
Point of Care Telemedicine Units for Surveillance of Infectious Disease 10/1/2010--6/30/2011 Dr. Gorbach is working with Dr. Karin Nielsen from the Department of Pediatrics as an investigator on project to introduce audio-computer assisted interviewing on handheld computers to assess high risk behaviors among women in pre-natal care in Brazil.
Completed Studies Rectal Health, Behaviors and Microbicide Acceptability.
This project has two studies designed to guide development of rectal microbicides by providing data on anal sex, anal health, and the acceptability of carrier methods for rectal microbicides. The first study will assess rectal health and behaviors among 896 men and women including HIV positive and negative subjects in Los Angeles and Baltimore. The Los Angeles sites include AIDS Research Association and UCLA CARE clinic. Enrollment is open until May, 2009. The second study is Acceptability of Three Rectal Applicators. This study will be enrolling January-May, 2009 and is being conducted at the UCLA CARE clinic. In the Pipeline (Barriers to Enrollment in Research Registry for Microbicides Clinical Trials).In the Pipeline: Rectal Microbicides: www.youtube.com/watch?v=rDvSTAkCbfM Bajo Investigacion: Microbicidas Rectal: www.youtube.com/watch?v=3oufqaPO_DY Project 2 of Network for AIDS Research in Los Angeles (NARLA). www.narla.med.ucla.edu
Project Manager: Leonardo Colemon: leocolemon@ucla.edu
Universitywide AIDS Research Program (UARP). This project in collaboration with community partners Friends Research Institute and AIDS Project Los Angeles, is conducting a cohort study of 450 men who have sex with men that will develop educational materials for men about rectal microbicides, assess the best format in which to deliver such information, identify barriers to microbicide trial participation by analyzing factors that facilitate enrollment in a microbicide trials registry, and measure STI and HIV incidence. HIV/AIDS Risk Behaviors in Methamphetamine User Networks. Additional Research
The Microbicide Trials Network (MTN), part of the Magee-Womens Research Institute and Foundation www.mwrif.org with affiliations to Magee-Womens Hospital magee.upmc.com of UPMC and the University of Pittsburgh www.pitt.edu, will be a worldwide collaborative clinical trials network that evaluates the safety and efficacy of microbicides designed to prevent HIV transmission. The mission of the MTN is to reduce the sexual transmission of HIV through the evaluation of microbicide products. The MTN will conduct scientifically rigorous and ethically sound clinical trials that will support licensure of topical microbicide products. The MTN plans to develop and/or execute 15 separate clinical trials of microbicides between 2006 and 2013. Established by the Division of AIDS www.niaid.nih.gov/daids of the National Institute of Allergy and Infectious Diseases, in partnership with other collaborating institutes at the National Institute of Health (NIH), the MTN carries out its mission through a strong network of expert scientists and investigators from domestic and international sites. Dr. Gorbach is the member of the Behavioral Research Working Group and a behavioral investigator on the following MTN trials/studies:
MTN 015: Observational Cohort Study of Women Following Seroconversion in Microbicide Trial MTN 009: HIV Resistance at Screening for HIV Prevention Trials MTN 018: Committed to Having Options for Interventions to Control the Epidemic: a Follow-up Study to MTN-003
|
|||